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Abstract 
BACKGROUND AND AIM: The effects of xerostomia on oral health have been studied for decades; however, the 
prevalence of this disorder in the general population remains controversial. The purpose of this study was to determine 
the prevalence of xerostomia in the population of Kerman, Iran. 
METHODS: A total of 1010 subjects participated in this cross-sectional study. Study volunteers completed a standardized 
questionnaire regarding demographic data, history of systemic disease, use of medication, cigarette smoking, and 
etcetera. The Fox questionnaire was also completed to diagnose xerostomia. 
RESULTS: The prevalence of xerostomia in this study was 55% (59.9% among men and 49.9% among women). The 
mean age of the study population was 34.7 ± 12.1. 21.5% of cases had a systemic disease and 19% reported taking 
medication. Moreover, 25.9% of the participants (30% men and 4.6% women) smoked cigarettes or other tobacco 
products. Systemic disease, medication, and the use of tobacco products and opiates were found to be significant risk 
factors for xerostomia. 
CONCLUSIONS: The prevalence of xerostomia in our study was higher than that reported in other populations. Smoking 
and medication were significant risk factors for xerostomia. 
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aliva is a complex and important body 
fluid that plays a significant role in the 
lubrication and protection of oral 
mucosa, remineralization of teeth, 
digestion, phonation, taste sensation, 
buffering action and clearance, and 
antibacterial activity. Therefore, this fluid is 
necessary for the integrity of the oral tissues 
and is critical for protection and maintaining 
of oral and dental health.1 Xerostomia (the 
subjective complaint of dry mouth) and 
salivary gland hypofunction (objective 
evidence of low saliva secretion) can have a 
deleterious effect on many aspects of oral 
function and general health; thus, they can 
cause a significant decline in the quality of 
life.2 The main causes of salivary gland 
hypofunction are medication, systemic 
diseases, and radiotherapy. 
Many studies have shown that there is 
great variability in the prevalence of dry 
mouth. In North of England, the prevalence 
of xerostomia in 1103 adult patients attending 
for routine dental care was 12.7% (14.4% 
females, 10.3% males), which was lower than 
reported in previous North American and 
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Swedish studies.3 In a systematic review in 
Scandinavia, the prevalence of xerostomia in 
the 13 articles ranged from 0.9% to 64.8%.4 In 
most studies, the self-reported diagnoses 
were obtained through a questionnaire 
administered to the patient.3,4 
In Iran some studies have examined the 
prevalence of xerostomia in specific 
individuals (with a serious disease, 
institutionalized elderly, and etcetera). For 
example, in Mashhad (northeast of Iran), the 
prevalence of xerostomia in 237 
institutionalized elderly people was 38%. 
This study showed that old age is a major 
factor in the decrease of salivary secretion 
and xerostomia.5 
As mentioned earlier, xerostomia affects 
important aspects of life such as speaking, the 
enjoyment and ingestion of food, and the 
wearing of dental prostheses.1-3 These impacts 
on the daily lives of patients lends support to 
the assertion that dry mouth is an important 
condition that merits concerted research 
attention for the further understanding of how 
best to treat and prevent it. Therefore, the 
knowledge of the prevalence of xerostomia 
among a population is very important. The 
aim of this study was to describe the 
prevalence of xerostomia in a population of 
Kerman, Iran, that was not clinic-based or 
limited to the elderly. 
Methods 
This study was approved by the Ethics 
Committee of Kerman University of Medical 
Sciences (code 86/66). In this study, 1010  
persons aged 18 years or over, who 
accompanied patients of the private and 
public dental clinics, were evaluated. We 
selected subjects that were relatives of the 
patients. They only accompanied the patient 
and at the time of the research had no dental 
and oral complaints. These individuals were 
selected for increased external validity. First, 
subjects were asked to participate and give 
written informed consents. Then they 
completed a form including age, gender, any 
details about the existence of systemic 
disease, menopause, current systemic 
medications, tobacco use, and the 
questionnaire of Fox et al (Table 1). 
In this study we determined the 
xerostomia level by asking subjects the 
questionnaire of Fox et al. about dry mouth. 
Translation and back-translation were used 
to develop a Farsi version of the 
questionnaire. First, two Iranian oral 
medicine specialists, fluent in English, 
performed a forward translation. Then, the 
translated text was translated back into 
English by a native English speaker and 
literature graduate. Thereafter, in one session, 
these three people discussed and approved 
unanimously that the translation was the 
same as the original English version. 
The reliability was assessed by measuring 
internal consistency reliability, for this we 
measured Cronbach’s alpha coefficient and 
item-scale correlation. The minimum 
acceptable level of Cronbach’s alpha and 
item-scale correlation was assumed 0.6 and 
0.4, respectively. 
 
Table 1. Fox and colleagues’s specific questions about dry mouth6 
Questions Yes No  
Does your mouth feel dry at night or on awakening? 
Does your mouth feel dry at other times of the day? 
Do you keep a glass of water by your bed? 
Do you sip liquids to aid in swallowing dry foods?* 
Does your mouth feel dry when eating a meal?* 
Do you have difficulties swallowing any foods?* 
Do you chew gum daily to relieve oral dryness? 
Do you use hard candies or mints daily to relieve oral dryness? 
   
Question about personal evaluation of the amount of saliva Too little Too much Do not notice it 
Does the amount of saliva in your mouth seem to be too little, too 
much, or you do not notice it?    
* These questions were correlated to objective measures of dry mouth in Fox and Colleagues’ 1978 study 
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For validity a sample of 20 subjects were 
interviewed, and the acceptability and 
meaning of the items were investigated. 
Then, the stimulated and unstimulated saliva 
of these subjects were measured. Validity 
was tested by using the sensitivity, 
specificity, receiver operating characteristics 
(ROC), and the Pearson correlation. Finally, 
the reliability and validity of this Persian 
version of the questionnaire were examined, 
and were recorded as an optimal level. Then, 
we identified subjects with dry mouth as 
those who answered yes to at least one of the 
three questions that were marked with a star 
(Table 1).6 Fox et al. showed these three 
questions, which focused on oral dryness 
associated with eating, were highly indicative 
of salivary performance.6,7 
We calculated sample size using the 
following formula n = z2 p(1-P)/d2 (z = 1.96, 
p = 0.3, d = 0.03). 
We conducted data analysis using SPSS 
for Windows (version 15; SPSS Inc., Chicago, 
IL., USA). We assessed intergroup 
comparisons by using the chi-squared test 
significant at levels of P < 0.05. 
Results 
The subjects’ mean age ± standard deviation  
(SD) was 34.2 ± 12.1 years (age range = 18-78 
years) and approximately 49.1 % (503) of the 
1010 subjects were women. Fifty five percent 
of the subjects (59.9% of all men and 49.9% of 
all women) reported experiencing at least one 
xerostomia symptom (need to sip liquids to 
aid in swallowing dry food, mouth feels dry 
when eating a meal, or have difficulties in 
swallowing any food). Men had experienced 
more symptoms of dry mouth compared 
with women (P < 0.001), but the difference 
between age groups was not significant. 
Overall, 27% of 1010 subjects reported 
experiencing one symptom, 16.9% reported 
experiencing two symptoms, and 10.4% 
reported experiencing all three symptoms 
(Figure 1). 
Approximately 21.5% of the subjects 
reported a history of systemic diseases. The 
most common diseases were cardiovascular 
diseases, hypertension, diabetes, and 
psychological diseases, respectively. 
Nineteen percent of the subjects reported 
taking medications. The most common 
medications used, respectively, were 
antihypertensives, hypoglycemics, and 
antidepressants.  
Symptoms of dry mouth were experienced 
significantly more among subjects who had a 
 
 
Figure 1: The frequency of positive answers to main questions of the questionnaire of Fox et al. 
Q1 = Does your mouth feel dry when eating a meal? 
Q2 = Do you sip liquids to aid in swallowing dry foods? 
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systemic disease (65%) or used certain 
medications (64.1%), compared with 
non-patients (52.2%) and those who did not 
use medications (52.8%) (Table 2). 
Most of the subjects did not use any form of 
tobacco, while approximately 7.8% of subjects 
were cigarette smokers, and 7.1% used a pipe. 
A total of 94% of the subjects reported taking 
no form of illegal drugs and the common drug 
used was opium (3.8%). Overall, 70% of men, 
and 95.4% of women did not use any form of 
tobacco and drugs. Approximately 74.5% of 
smokers and 73.8% of drug addicts reported 
experiencing xerostomia symptoms. There 
was a significant relationship between 
smoking and drug use, and experienced 
symptoms of dry mouth (P < 0.001 and 
P < 0.002 respectively). 
The quantity of saliva by 67.7% of the 
subjects was reported as normal and 19.3% as 
little or too little (Figure 2). A significant 
number of subjects who were older 
(compared with younger subjects), had a 
history of systemic diseases (compared with 
non-patients), used certain medications 
(compared with non-users of medications),  
were smokers (compared with non-smokers), 
and used drugs (compared with non-users of 
drugs), assessed the quantity of their saliva as 
little or too little. 
Discussion 
In this study, we found that 55% of the 
subjects reported the sensation of oral 
dryness. The results of a systematic review 
showed that the prevalence of xerostomia 
in 13 selected articles ranged from 0.9 to 
64.8%. In all articles, similar to our study, 
the xerostomia level was determined by 
asking subject specific questions about dry 
mouth.4 In some studies only one question 
was asked about dry mouth.3,8 Therefore, it 
seems that a wide range of the prevalence 
of xerostomia in the literature is related to 
the variation in number and content of the 
questions, and guidelines for the diagnosis 
of xerostomia. Since the study-population 
in this study was selected of persons that 
accompanied patients to the private and 
public dental clinic, we can say that the 
findings of this study can be generalized to 
other individuals. 
 
Table 2. Relationship of xerostomia with systemic disease, and medications  
Xerostomia P No Yes 
Number (%) Number (%) 
Systemic diseases Yes P = 0.001 76 (35.0) 141 (65.0) 
No  397 (47.8) 414 (52.2) 
Medication Yes P = 0.005 69 (35.9) 123 (64.1) 
No  386 (47.2) 432 (52.8) 
Frequency (%) positive answers to main questions 
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We found that in the population of Kerman 
59.9% of 507 men reported having symptoms 
of dry mouth, which was higher than 
American men (18%), English men (10.3%), 
and Swedish men (21.3%).6,8,9 
Moreover, we found that 49.9% of 503 
women reported having symptoms of dry 
mouth, and that was lower than men. This 
result was similar to studies in Japan, and 
Saudi Arabia.10,11 In these studies, the 
prevalence of xerostomia in men was higher 
than women. However, in the majority of the 
studies women had experienced more 
symptoms of dry mouth than men.3,4,8,12 In 
some studies the prevalence of xerostomia 
was similar in men and women.13,14 
In our study similar to the majority of 
studies, we selected subjects that were 18 years 
or older.3,8,9 Some studies have shown that the 
incidence of xerostomia increased with age.3,8,15 
Whereas other researchers have demonstrated 
that there is no association between age and 
symptoms of dry mouth, and this finding was 
in accordance with our study.13,16 
In the present study, there was a 
significant relationship between the sensation 
of oral dryness, and medication and systemic 
diseases. The most common diseases were 
cardiovascular diseases, hypertension, 
diabetes, and psychological diseases. 
Therefore, the most common medications 
used were antihypertensives, hypoglycemics, 
and antidepressants, respectively. 
Many studies have shown that drugs, 
especially those with anticholinergic activity 
are the most common cause of reduced 
salivation. Therefore, the complaint of dry 
mouth is common, particularly in patients 
treated for hypertensive and psychiatric 
problems. However, the relationship between 
medications and dry mouth is a complex one 
and differs according to which aspect of dry 
mouth is being examined.17 
As mentioned earlier in our study, there 
was a significant relationship between the 
sensation of oral dryness, and medication and 
common systemic diseases. A study in the 
United States showed that complaints of dry 
mouth in patients taking cardiovascular drugs 
had increased.18 In other studies, persons with 
chronic mental illness or diabetes had 
significantly higher incidences of self-reported 
dry mouth and reduced salivary flow 
compared with a control group.19,20 
The effect of smoking on reduction of 
salivary flow, and dry mouth is controversial. 
Thomson et al. showed that unstimulated 
flow rate was higher among smokers.17 Some 
studies have shown that xerostomia was 
more commonly observed among cigarette 
smokers.9,11,21 A longitudinal study in Sweden 
showed that smoking had been significantly 
associated with daytime xerostomia but not 
with night-time xerostomia.22 Other studies 
reported that cannabis smoking and 
Methamphetamine abuse has been 
significantly associated with xerostomia.23,24 
The present study also showed that the 
prevalence of xerostomia was higher in 
smokers and drug users. Considering that 
drug use is not acceptable in society, it is 
likely that the statistics obtained in this study 
is lower than the reality. However, in this 
study there was a significant relationship 
between the use of drugs and dry mouth. 
It seems that the higher prevalence of drug 
use and smoking among men than women 
(30% in men compared with 6.4% in women) as 
well as the higher percentage of systemic 
diseases in men than women in the study 
population (1.24% in men and 8.18% in 
women) can cause men to experience more 
xerostomia symptoms compared with women. 
The personal evaluation of the amount of 
saliva showed that those who reported that 
the amount of saliva in their mouth seemed 
to be little or too little (19.3%) were 
significantly more than those that reported 
their saliva seemed to be too much or they 
did not notice any xerostomia symptoms. 
This finding emphasizes the importance of 
the use of different diagnostic methods for 
xerostomia in various studies. As mentioned 
earlier, the results of a systematic review 
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showed that the prevalence of xerostomia in 
the 13 selected articles ranged from 0.9% to 
64.8%.9 Some of these studies determined the 
prevalence of xerostomia by only personal 
evaluation of saliva amount. 
Conclusion 
The prevalence of xerostomia in our study 
was higher than that reported in other 
populations. Smoking and medication were 
significant risk factors for xerostomia. 
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